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PREINCUBATION of pulmonary microvascular endothelial
cells (PMVECs) with platelet-activating factor (PAF) for
3.5 h increased the adhesion rate of polymorphonuclear
leukocytes (PMNs) to PMVECs from 57.3% to 72.8% (p <
0.01). Preincubation of PMNs with PAF also increased
PMN-PMVEC adhesion rate. All-trans retinoic acid (RA)
blocked the adherence of untreated PMNs to PAF-
pretreated PMVECs but not the adherence of PAF-
pretreated PMNs to untreated PMVECs. PAF increased the
expression of intercellular adhesion molecule-1 (ICAM-1)
and E-selection (ELAM-1) on PMVECs, PMN chemotaxis to
zymosan-activated serum and histamine, and PMN aggre-
gation and the release of acid phosphatase from PMNs.
Co-incubation ofRA inhibited PAF-induced PMN aggrega-
tion, the release of acid phosphatase from PMNs, and
PMN chemotaxis to zymosan-activated serum and hista-
mine while the expression ofICAM-1 and ELAM-1 did not
change. Our results suggest that RA can be used to amel-
iorate PMN-mediated inflammation.
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Introduction
Polymorphonuclear neutrophils (PMNs) play a key
role in the inflammatory response underlying many
diseases. PMNs are capable of chemotaxis,
phagocytosis, oxygen-free radical production, and
degranulation in response to a variety of stimuli.
Overstimulation of PMNs can result in host tissue
injury. Inhibition ofPMN functions may be beneficial
to inflammatory diseases such as systemic inflamma-
tory reaction syndrome. During inflammation,
leukocytes may adhere firmly in microvascular
endothelial cells (ECs) whereupon they project
pseudopodia and migrate across endothelial
monolayers into traumatized interstitia through
diapedesis. The localized adhesion of leukocytes to
ECs is mediated at least partly by adhesion molecules
on leukocytes and their counterpart molecules on
ECs such as intercellular adhesion molecule-1 (ICAM-
1) and E-selectin (ELAM-1).
All-trans retinoic acid (RA) has beneficial effects
when used in a variety of inflammatory skin condi-
tions. Retinoids significantly inhibit the migration of
neutrophils from the blood into tissues in volun-
teers. This study observed the effects of PAF and RA
on the functions of polymorphonuclear neutrophil
leukocytes (PMNs) and the adhesion of PMNs to
pulmonary microvascular endothelial cells
(PMVECs).
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Materials and Methods
Reagents: Monoclonal antibodies 1.2B6 (anti-human
ELAM-1) and 6.5 (anti-human ICAM-1) were gifts of
D. O. Haskard, Royal Postgraduate Medical School,
University of London. All-trans retinoic acid,
Dulbecco’s Modified Eagle Medium (DMEM) and
dextran T500 were purchased from Sigma. Other
reagents were purchased from Shanghai Chemical
Reagent Co.
Zymosan activated serum: Zymosan A was sus-
pended in normal rat serum at a concentration of 2
mg/ml and incubated at 37C for 30 min. Then the
serum was centrifuged at 1500 x g for 10 min. The
supernatant was divided into aliquots and kept
frozen at-20C until use.
Isolation of endothelial cells: Sprague-Dawley rats
weighing 80-100 g were anaesthetized with urethane
(2 g/kg body weight) and heparinized (1000 units
per animal) intraperitoneally. The animals were
exsanguinated by cutting bilateral carotid arteries.
The blood remaining in the pulmonary vascular bed
was washed out with Hanks’ solution. The lungs
were isolated. The tissues of the lung surface or edge
were cut into separate pieces of 1 x 1 x 1.5 mm
dimensions. Ten pieces were placed in a flask with
a 45 cm bottom surface and cultured in DMEM
supplemented with 20% foetal bovine serum. No
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antibiotics, growth factors or extracellular matrix
proteins were added. After 60 h culture, the tissues
were discarded and the medium partially changed.
The flask contained only ECs and blood cells. The
cells were subcultured with 0.08% trypsin in Hank’s
solution without calcium between days 6 and 10. The
cells were identified as pulmonary PMVECs accord-
ing to morphological and functional criteria.
Measurement of PMN-PMVEC adherence.. PMNs
were isolated from heparinized rat blood with
dextran sedimentation and centrifugation on
Ficoll-Hypaque discontinuous density as reported
previously. Cell viability determined by the Trypan
Blue exclusion test was more than 99%. To reduce
the variations in the experiment, the adherence of
PMNs to PMVECs in 96-well plates was measured by
the following two methods. PMNs (1.0 x 105/well) in
Hanks’ solution were added to PMVEC monolayers
(4 10 cells/well) pretreated as in the experimental
protocol. After incubation at 37C in 5% CO2 and 95%
air for 30 min, PMVEC monolayers with adherent
PMNs were washed gently with the culture medium.
First, the number of adhered PMNs was calculated
from the counting difference between PMNs added
and aspirated (total cell count of the aspirated wash-
ing medium). Secondly, the number of adhered
PMNs was calculated by using phase-contrast
microscopy. The total number of adhered PMNs
(the area of one culture well/the area of one field of
view) x the number of adhered PMNs of one field of
view. The results were expressed as the percentage
increase compared with the control. The results from
the two methods were not significantly different. The
average data obtained by the two methods was
presented in the results.
Determination of the expression of ICAM-1 and
ELAM-1 on PMVECs by using ELISA: PMVECs were
plated in 96-well microtitre plates at a concentration
of 4 x 10 cells and were preincubated with culture
media alone, PAF (10-8 mol/1) and PAF plus RA (4 x
10-9 mol/1) for 4 h at 37C. Culture supernatant (100
btl) containing monoclonal antibodies 1.2B6 or
6.5B% was added. The plates were incubated at 37C
for 30 min. After washing, 100 1 peroxidase-conju-
gated goat anti-mouse IgG, diluted 1:500, was added
to each well and the plates were incubated for 30
min. The plates were washed again, o-Phenyl-
enediamine (100btl) and 301.tg H202 in 1001.tl
citrate-phosphate buffer (pH 5.0) were added. The
plates were incubated at 37C for 30 min. The
chromogenic reaction was stopped with 100 btl 2N
H2SO and the plates read spectrophotometrically at
492 nm on an ELISA reader (DG 3022A, East China
Electron Tube Factory).
The effects of RA on PMN-PMVEC adherence: The
ECs were cultured to a confluent monolayer on 96-
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well plates and preincubated for 3.5 h with culture
media alone, PAF (10-8 mol/1) and RA (4 x 10-9 mol!
1) plus PAF. All the media used were adjusted to
contain 0.1% alcohol to prevent precipitation of RA.
PMNs (1 x 105 cells/well) were added and incubated
for 30 min. The adhesion rate was measured as
described elsewhere. PMNs were preincubated in the
same way as that used for PMVECs. After
preincubation, PMNs were added to untreated
PMVECs and the adhesion rate was measured.
Chemotaxis assay: PMN chemotaxis was measured as
describe by Nelson. PMNs were suspended in cul-
ture medium containing RA (0, 10
-8 and 10-l mol/1).
PMNs at a concentration of 1 x 105 cells/well were
added to agarose holes (ten holes in each group) and
incubated at 37C in 5% CO2 for 18 h. The cells were
dehydrated in 75% ethanol and stained by Wright’s
method. The distance of the migration front towards
the wells containing either zymosan-activated serum
(ZAS) or histamine (8.7 x 10-8 mol/1) were measured
with an internal microscope micrometer.
PMN aggregation: PMNs were preincubated with RA
(1.8 x 10-9 mol/1) or medium alone for 4 h. The PMN
aggregation caused by PAF was determined on a PPP
automatically balanced platelet aggregator (Shanghai
Keda Apparatus Factory). PAF (50 l.tl, 10-8 mol/1)
caused maximal aggregation. PAF (30 btl, 10-8 mol/1)
was used to measure the samples. PMN aggregation
(%) PMN aggregation of sample x 100%/maximal
PMN aggregation.
The release of acid phosphatase from PMNs: PMNs
were incubated with control medium, PAF (10-8 mol!
1) alone or PAF (10-8 mol/1) plus RA (10
-11 to 10
-8 mol!
1) for 4 h with ten samples in each group. The PMNs
were then centrifuged and acid phosphatase activity
of the supernatant was measured by using a
colorimetric method.
Statistical analyses: Data are expressed as the mean
+ S.E.M. Statistical analyses were performed by
unpaired Student’s t-tests.
Results
The effects ofRA on PMN-PMVEC adherence: Stimu-
lation of PMVEC with PAF for 3.5 h increased
PMN-PMVEC adhesion rate by 27%. In the presence
of RA, the ability of PAF to increase adhesion rate
decreased significantly (Fig. 1). Preincubation of
PMNs with PAF also increased PMN-PMVEC adhe-
sion rate significantly (p < 0.01). RA did not block
the adhesion of PAF-pretreated PMNs to PMVECs
(Fig.. 1).
Expression ofELAM-1 and ICAM-1 on PMVECs: PAF
increased the expression of both ELAM-1 and ICAM-Retinoic acid inhibits neutrophilfunctions
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FIG. 1. The effects of RA on the adherence of untreated PMNs to PAF-
treated PMVECs (treated PMVECs) and the adherence of PAF-treated
PMNs to untreated PMVECs (treated PMNs). n 8. **p < 0.01 vs RAo
1, whereas RA did not influence the expression of
these two molecules (Fig. 2).
PMN chemotaxis: Chemotaxis distances of control
PMNs to ZAS and histamine were 344.2 + 6.0M and
270.0 + 7.34 l.tM, respectively. RA decreased ZAS or
histamine-induced PMN chemotaxis (Table 1).
PMN aggregation: RA decreased PAF-induced PMN
aggregation from 73.0 + 2.5% to 57.5 + 3.4% (p <
0.01).
The release of acid phosphatase from PMNs: PAF
increased the release of acid phosphatase signifi-
cantly whereas RA (10-12 to 10
-8 mol/1) did not affect
the release of acid phosphatase.
Discussion
Acute inflammatory reactions are characterized by
the local accumulation of leukocytes at the inflamma-
tory sites. A major target of inflammatory mediators
is endothelial cells, which in vitro may express sev-
eral mediator-inducible cell-surface molecules that
bind leukocytes through specific ligand interaction.
ELAM-1 and ICAM-1 mediate the attachment ofPMNs
to endothelial cells.
PAF is one of the major mediators of inflammatory
reactions, such as those elicited by liposaccharide.
ELAM- CAM-
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FIG. 2. The effects of PAF and RA on the expressions of ICAM-1 and
ELAM-1 on PMVECs. n 8. **p < 0.01 vs PAF.
Table 1. The effect of retinoic acid on PMN chemotaxis to
zymosan-activated serum and histamine
Retinoic acid
concentration
Chemotaxis distance (l.tM)
Zymosan-activated serum Histamine
0 (control) 270.0 _+ 7.3 344.2 + 6.0
10-9 253.8 +_ 7.9** 302.0 + 7.1
10-8 191.3 + 3.3** 265.5 + 4.7**
**p < 0.01 vs control, n 10.
PAF increases PMN adhesion and degranulation.
8-1
PAF may be a common messenger signalling the
increase of leukocyte adherence to endothelial cells
elicited by a group of mediators, such as thrombin,
leukotriene C4 and D4, H202 and interleukin-2.11-13
The present study showed that PAF increased PMN
aggregation, PMN-PMVEC adhesion, the release of
acid phosphatase from PMNs, and the expressions of
ELAM-1 and ICAM-1 on PMVECs. PAF-induced
PMN-EC (endothelial cell) adhesion was both pro-
tein synthesis dependent and independent. PAF
increased CD18 expression on PMNs. 14 Hattori et al.
reported that intracellular granule components GMP-
140 in ECs might translocate to the cell surface
rapidly when ECs were activated by histamine,
thrombin, phorbol myristate acetate or A23187.15
Whether GMP-140 takes part in the process of PAF-
induced PMN-EC adhesion is unknown. PAF is a
phospholipid and may insert into the membrane lipid
bilayer. Washing EC monolayers after PAF treatment
did not decrease PMN adherence. PAF may stimulate
the production and the release of other mediators.
Many PAF-induced mediators may increase PMN-EC
adhesion. In conclusion, four possible mechanisms
exist in PAF-induced PMN-EC adhesion: (1) the
expression of ELAM-1 and ICAM-1 on ECs, and CD18
on PMNs; (2) the translocation of GMP-140 in ECs;
(3) the interaction of EC-bound PAF with PAF
receptors on PMN membranes; and (4) the actions of
PAF-induced mediators.
Endothelial cells express a retinoic acid receptor.
16
RA decreased scalding- and platelet-activating factor-
induced pad oedema and high vascular permeability
of rats (authors’ unpublished data). Retinoids amel-
iorated the injury in rat lung and skin sites after
treatment with bovine serum albumin and antibodies
to bovine serum albumin. 17 Twenty-four hours fol-
lowing RA treatment, endothelial cells occupied a
greater area than control.
18 Retinoids inhibited prolif-
eration of endothelial cells from skin and aorta,m but
it is reported that RA enhanced the mitogenic effect
of epidermal growth factor on cultured bovine
corneal endothelial cells,a Thus, retinoids may play
a role in the regulation of endothelial cell function.
In this experiment, it is found that although RA
decreased PAF-induced adherence of PMNs to PAF-
pretreated PMVECs, the expressions of ELAM-1 and
ICAM-1 on PMVECs did not change significantly. The
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inhibition of PMN-PMVEC adhesion by RA may not
be due to the decrease in the expression of ICAM-1
and ELAM-1.
Since RA inhibited the adherence of fresh PMNs to
PAF-pretreated PMVECs but not PAF-pretreated
PMNs to untreated PMVECs, RA probably inhibited
PMN-PMVEC adhesion by affecting PMVEC reactiv-
ity.
Retinoids inhibited the migration ofPMNs from the
blood to tissues. RA inhibited superoxide anion
production, proteolytic enzyme and arachidonic acid
release from PMNs. 17,21 Robinson reported that all-
trans-retinal stimulated O2 release but not granule
exocytosis.
22 Retinoids inhibited tumour necrosis fac-
tor and nitric oxide production of murine peritoneal
macrophages,23 and interleukin-l-induced cytokine
synthesis in human monocytes and lung
fibroblasts. 24,25 RA treatment inhibited degranulation
of extracellular matrix and type IV collagen by 50 to
60%. 26 Most of the mediators reduced by retinoids are
pro-inflammatory mediators. In this experiment, RA
inhibited PMN adhesion, aggregation and chemo-
taxis. Thus, retinoids may be a group of effective
anti-inflammatory compounds.
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